Bio-Techne Q4 FY26: where the revenue came from and where it went
The whole income statement of Bio-Techne for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2026
- Reported
- Aug 24, 2026
Revenue$0.32B
+1% year over year
Gross profit$0.21B
66% margin
Operating profit$0.07B
23% margin
Net profit$0.06B
17% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.32 | 100% | +1% |
| Protein sciences | 0.23 | 70% | |
| Diagnostics | 0.09 | 27% | |
| Other revenue | 0.01 | 3% | |
| Cost of revenue | −0.11 | 34% | |
| Gross profit | 0.21 | 66% margin | +3pp |
| SG&A | −0.11 | 35% | −27pp |
| Other | −0.02 | 8% | +0pp |
| Operating profit | 0.07 | 23% margin | +31pp |
| Interest & other costs | −<0.01 | ||
| Tax | −0.02 | ||
| Net profit | 0.06 | 17% margin | +23pp |
39 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest